Michael R Minogue - Net Worth and Insider Trading

Michael R Minogue Net Worth

The estimated net worth of Michael R Minogue is at least $192 Million dollars as of 2024-12-28. Michael R Minogue is the Chairman, President, CEO of Abiomed Inc and owns about 495,000 shares of Abiomed Inc (ABMD) stock worth over $189 Million. Michael R Minogue is also the Director of Insulet Corp and owns about 14,073 shares of Insulet Corp (PODD) stock worth over $4 Million. Details can be seen in Michael R Minogue's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael R Minogue has not made any transactions after 2023-05-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael R Minogue

To

Michael R Minogue Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael R Minogue owns 2 companies in total, including Abiomed Inc (ABMD) , and Insulet Corp (PODD) .

Click here to see the complete history of Michael R Minogue’s form 4 insider trades.

Insider Ownership Summary of Michael R Minogue

Ticker Comapny Transaction Date Type of Owner
ABMD Abiomed Inc 2021-08-23 director & President & CEO
PODD Insulet Corp 2023-05-23 director

Michael R Minogue Latest Holdings Summary

Michael R Minogue currently owns a total of 2 stocks. Among these stocks, Michael R Minogue owns 495,000 shares of Abiomed Inc (ABMD) as of August 23, 2021, with a value of $189 Million and a weighting of 98.06%. Michael R Minogue also owns 14,073 shares of Insulet Corp (PODD) as of May 23, 2023, with a value of $4 Million and a weighting of 1.94%.

Latest Holdings of Michael R Minogue

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABMD Abiomed Inc 2021-08-23 495,000 381.02 188,604,900
PODD Insulet Corp 2023-05-23 14,073 265.12 3,731,034

Holding Weightings of Michael R Minogue


Michael R Minogue Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael R Minogue has made a total of 5 transactions in Abiomed Inc (ABMD) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Abiomed Inc is the sale of 3,492 shares on August 23, 2021, which brought Michael R Minogue around $1 Million.

According to the SEC Form 4 filings, Michael R Minogue has made a total of 1 transactions in Insulet Corp (PODD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Insulet Corp is the acquisition of 3,300 shares on May 23, 2023, which cost Michael R Minogue around $1 Million.

Insider Trading History of Michael R Minogue

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael R Minogue Trading Performance

GuruFocus tracks the stock performance after each of Michael R Minogue's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael R Minogue is -36.4%. GuruFocus also compares Michael R Minogue's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael R Minogue within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael R Minogue's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael R Minogue

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.89 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -7.78 LIMIT LIMIT LIMIT LIMIT LIMIT

Michael R Minogue Ownership Network

Ownership Network List of Michael R Minogue

No Data

Ownership Network Relation of Michael R Minogue

Insider Network Chart

Michael R Minogue Owned Company Details

What does Abiomed Inc do?

Who are the key executives at Abiomed Inc?

Michael R Minogue is the director & President & CEO of Abiomed Inc. Other key executives at Abiomed Inc include VP & GLOBAL OPERATIONS Matthew T. Plano , Chief Operating Officer David M Weber , and Vice President & CFO Todd A Trapp .

Abiomed Inc (ABMD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Abiomed Inc (ABMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Abiomed Inc (ABMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Abiomed Inc (ABMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Abiomed Inc Insider Transactions

No Available Data

Michael R Minogue Mailing Address

Above is the net worth, insider trading, and ownership report for Michael R Minogue. You might contact Michael R Minogue via mailing address: 22 Cherry Hill Dr, C/o Abiomed Inc, Danvers Ma 01923.

Discussions on Michael R Minogue

No discussions yet.